NCT06915922View on ClinicalTrials.gov

YAG Laser Vitreolysis for Vitreous Floaters

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Posterior Vitreous DetachmentMyopic VitreopathyVISION DEGRADING MYODESOPSIA
Interventions
DEVICE

Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser therapy

Nd:YAG laser treatment(s) for Vision Degrading Myodesopsia (clinically significant vitreous floaters) in eyes with vitreous opacities due to myopic vitreopathy and posterior vitreous detachment (PVD).

Trial Locations (1)

92647

RECRUITING

VMR Institute for Vitreous Macula Retina, Huntington Beach

All Listed Sponsors
collaborator

Quantel Medical

INDUSTRY

lead

VMR Consulting, Inc.

OTHER